Kata® ends treatment errors


A new era in the treatment of respiratory diseases

All patients suffer from a significant problem: the success of their treatment heavily depends on the correct usage of their inhalers. The drug must reach the lungs to be effective. Today’s problem of quantity: there are too many inhalers. Patients, doctors and the entire healthcare system suffer from a crowded and confusing market. In Germany alone, more than 160 different combination preparations with MDI and DPI inhalers are approved. The resulting application errors are expensive and fatal.

The consequences

  • 90% of patients fail to use the device correctly[1][2][3]
  • 50% of the resulting errors are so-called critical errors, i.e. they have a negative effect on the dose that still reaches the lungs[1][2][3]
  • Poor patient inhalation technique correlates with poor disease progression and severe exacerbations[4][5]

[1] Respiratory Medicine (2008) 102, 593–604
[2] Respiratory Medicine (2011) 105, 930e938
[3] Respiratory Medicine (2013) 107, 37e46
[4] Price et. al. Inhaler errors in the CRITIKAL study
[5] Molimard et. al. Eur Respir J 2017; 49: 1601794

Kata® - The specifics


A comprehensive therapy enhancement

Personalized digital assistant for asthma and COPD patients. Trains the best possible therapy efficiency.

Real-time training for patients during daily use. Ensures an appropriate, reproducible dose in the lungs for effective treatment.

Transversal use, adapted to all inhaler types. Does not require expensive and cumbersome adjustments of hardware components.

Daily symptom and therapy records. Allows physicians to make well-informed therapy decisions.

Reports on disease progression and adherence by Kata®. Enable patients to monitor their medication and detect subtle changes.

Collection of anonymised data by Kata®. Supports the optimisation of the respective medication and methodology.

Personalized digital assistant for asthma and COPD patients. Trains the best possible therapy efficiency.

Real-time training for patients during daily use. Ensures an appropriate, reproducible dose in the lungs for effective treatment.

Transversal use, adapted to all inhaler types. Does not require expensive and cumbersome adjustments of hardware components.

Daily symptom and therapy records. Allows physicians to make well-informed therapy decisions.

Reports on disease progression and adherence by Kata®. Enable patients to monitor their medication and detect subtle changes.

Collection of anonymised data by Kata®. Supports the optimisation of the respective medication and methodology.

Kata® can be adapted to any inhaler without hardware changes.

A digital solution. For all inhalers.

Easy usage, great therapy success

The health app, installed on the smartphone, shows users how to inhale correctly in a simple and understandable way. In addition, the app reminds users to inhale and assesses whether they have completed the individual steps of their inhalation process to ensure that the active substance is delivered to the lungs in the best possible way. Currently ready for use with the most common inhalers (MDIs/dosage inhalers and Respimat), the purely digital therapy solution can be adapted very quickly to all common inhalation devices (dry powder inhalers, spacers, nebulisers).

The smart inhalation assistant

Kata® reports in text and image how successful an inhalation application was and documents the user’s behaviour. The data is anonymous and gives anonymous information about the course of disease and application habits. The digital technologies help those affected to improve the usage of all common inhalation devices as part of their inhalation therapy. The administration of active substances or drugs is significantly optimized, and the success of treatment and therapy is improved. Respiratory therapies are immediately much easier and more effective for patients.

Inhalation training

Kata® eliminates usage errors through automated inhalation training and immediate feedback to patients.

Adherence Management

Kata® offers continuous care and comprehensive therapy support as digital therapy support.

Diversity

Kata® requires no additional hardware and can be adapted to any inhaler.

Big Data

Kata® enables better future treatment measures as a source of large amounts of data (anonymised).

Patients can find further information and the link to download the app at www.kata-inhalation.com.